TBX3 (T-box transcription factor TBX3) variants and mutations
TBX3 (also known as T-box transcription factor TBX3) is a human protein-coding gene encoding a t-box transcription factor protein. It represses and activates developmental gene programs involved in limb, mammary, genital, and cardiac conduction-system formation. Haploinsufficiency causes ulnar-mammary syndrome, while abnormal expression can contribute to cancer-cell plasticity and invasion. This analysis covers 697 TBX3 variants and mutations. Of these, 73% have computational variant effect predictions. Disease context includes ulnar-mammary syndrome, breast carcinoma, and Abnormality of the skeletal system. Example TBX3 variants include S2R, S2T, and L3R.
Variant analysis overview
- Gene: TBX3
- Protein: T-box transcription factor TBX3
- UniProt accession: O15119
- Organism: Homo sapiens
- Variants analyzed: 697
- Variant scope: all variants
- Completed: 2026-08-22
Variant and mutation evidence
- Variant composition: 278 unspecified-consequence records; 1 stop retained variant; 2 stop lost; 11 frameshift variants; 79 synonymous variants; 310 missense variants; 11 stop-gained variants; 6 in-frame deletions; 2 in-frame insertions; 1 substitution
- Prediction scores: 509 variants have prediction scores (73% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: ulnar-mammary syndrome, breast carcinoma, Abnormality of the skeletal system, breast adenocarcinoma, hereditary disease, atrial fibrillation, prostate carcinoma, colorectal adenocarcinoma, polyp of colon, hypertensive disorder, ovarian endometriosis, colorectal cancer.
Protein structure and variant hotspots
- Protein features: 8 post-translational modification sites.
- PTM context: 6 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable TBX3 variants
Examples include S2R, S2T, L3R, M5I, A16T, D27Y, V33L, Q37H. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- S2R (p.Ser2Arg), NCI-TCGA Cosmic COSV9998, cosmic curated COSV99984, Ensembl rs1869023666, REVEL 0.20, CADD 22.90, Variant assessed as somatic; moderate impact.
- S2T (p.Ser2Thr), rs1869023810, ClinGen CA386873584, ClinVar RCV003619992, AlphaMissense 0.10, MetaLR 0.28, Uncertain significance, Ulnar-mammary syndrome
- L3R (p.Leu3Arg), rs2499799927, ClinGen CA386873577, ClinVar RCV004474319, Uncertain significance, Inborn genetic diseases
- M5I (p.Met5Ile), NCI-TCGA Cosmic COSV5747, cosmic curated COSV57473, Variant assessed as somatic; moderate impact.
- A16T (p.Ala16Thr), NCI-TCGA Cosmic COSV9998, cosmic curated COSV99983, Variant assessed as somatic; moderate impact.
- D27Y (p.Asp27Tyr), NCI-TCGA Cosmic COSV5747, cosmic curated COSV57471, Variant assessed as somatic; moderate impact.
- V33L (p.Val33Leu), rs2499799706, ClinGen CA2739277321, ClinVar RCV003620606, REVEL 0.30, CADD 22.70, Uncertain significance, Ulnar-mammary syndrome
- Q37H (p.Gln37His), NCI-TCGA TCGA novel, Ensembl rs2121160015, Variant assessed as somatic; moderate impact.
- F40L (p.Phe40Leu), NCI-TCGA TCGA novel, REVEL 0.78, CADD 27.90, Variant assessed as somatic; moderate impact.
- P47L (p.Pro47Leu), rs769065791, NCI-TCGA TCGA novel, ClinGen CA386873302, ClinVar RCV003620556, AlphaMissense 0.44, MetaLR 0.80, Uncertain significance, Ulnar-mammary syndrome
- P48S (p.Pro48Ser), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A51G (p.Ala51Gly), NCI-TCGA Cosmic COSV5747, Variant assessed as somatic; moderate impact.
- A51T (p.Ala51Thr), rs1565862637, ClinGen CA386873282, NCI-TCGA Cosmic COSV9998, cosmic curated COSV99983, AlphaMissense 0.08, MetaLR 0.67, Uncertain significance, Ulnar-mammary syndrome
- S55L (p.Ser55Leu), NCI-TCGA TCGA novel, REVEL 0.57, CADD 24.30, Variant assessed as somatic; moderate impact.
- G70W (p.Gly70Trp), rs1006993913, TOPMed rs1006993913, gnomAD rs1006993913, AlphaMissense 0.79, MetaLR 0.80, Variant assessed as somatic; moderate impact.
- P77L (p.Pro77Leu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G82R (p.Gly82Arg), NCI-TCGA Cosmic COSV5747, cosmic curated COSV57470, REVEL 0.72, CADD 27.70, Variant assessed as somatic; moderate impact.
- P83S (p.Pro83Ser), NCI-TCGA Cosmic COSV5747, REVEL 0.25, CADD 22.90, Variant assessed as somatic; moderate impact.
- Q84R (p.Gln84Arg), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- P89H (p.Pro89His), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- K91N (p.Lys91Asn), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- K91T (p.Lys91Thr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- P95H (p.Pro95His), NCI-TCGA TCGA novel, Ensembl rs2121158772, REVEL 0.56, CADD 31.00, Variant assessed as somatic; moderate impact.
- E96V (p.Glu96Val), NCI-TCGA Cosmic COSV9998, cosmic curated COSV99983, Variant assessed as somatic; moderate impact.
- E97D (p.Glu97Asp), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- E98* (p.Glu98Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- E98D (p.Glu98Asp), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- D102R (p.Asp102Arg), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- P103H (p.Pro103His), NCI-TCGA TCGA novel, Ensembl rs2121158551, Variant assessed as somatic; moderate impact.
- P103T (p.Pro103Thr), NCI-TCGA Cosmic COSV5747, cosmic curated COSV57474, Variant assessed as somatic; moderate impact.
- K104V (p.Lys104Val), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- V105A (p.Val105Ala), NCI-TCGA Cosmic COSV5747, NCI-TCGA Cosmic COSV9998, cosmic curated COSV99984, Variant assessed as somatic; moderate impact.
- L107M (p.Leu107Met), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A109S (p.Ala109Ser), NCI-TCGA Cosmic COSV9998, cosmic curated COSV99984, REVEL 0.46, CADD 22.50, Variant assessed as somatic; moderate impact.
- A109V (p.Ala109Val), NCI-TCGA Cosmic COSV5747, cosmic curated COSV57470, Variant assessed as somatic; moderate impact.
- K110* (p.Lys110Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- E111* (p.Glu111Ter), NCI-TCGA Cosmic COSV5746, cosmic curated COSV57469, Variant assessed as somatic; high impact.
- L112R (p.Leu112Arg), NCI-TCGA Cosmic COSV5747, cosmic curated COSV57473, Variant assessed as somatic; moderate impact.
- L112V (p.Leu112Val), NCI-TCGA Cosmic COSV5747, NCI-TCGA Cosmic COSV9998, cosmic curated COSV99984, Variant assessed as somatic; moderate impact.
- W113* (p.Trp113Ter), NCI-TCGA Cosmic COSV5747, cosmic curated COSV57473, Variant assessed as somatic; high impact.
- W113G (p.Trp113Gly), rs2121158390, ClinGen CA386872783, NCI-TCGA Cosmic COSV5747, ClinVar RCV001823052, AlphaMissense 1.00, MetaLR 0.97, Likely pathogenic, Ulnar-mammary syndrome
- W113R (p.Trp113Arg), NCI-TCGA Cosmic COSV5747, cosmic curated COSV57475, Variant assessed as somatic; moderate impact.
- Q115* (p.Gln115Ter), NCI-TCGA Cosmic COSV5747, cosmic curated COSV57470, Ensembl rs2121158347, Variant assessed as somatic; high impact.
- Q115R (p.Gln115Arg), NCI-TCGA Cosmic COSV5747, cosmic curated COSV57474, Variant assessed as somatic; moderate impact.
- F116L (p.Phe116Leu), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- K118R (p.Lys118Arg), NCI-TCGA Cosmic COSV9998, cosmic curated COSV99983, REVEL 0.51, CADD 31.00, Variant assessed as somatic; moderate impact.
- G120C (p.Gly120Cys), rs985381779, NCI-TCGA Cosmic COSV5746, cosmic curated COSV57469, gnomAD rs985381779, REVEL 0.87, CADD 29.50, Variant assessed as somatic; moderate impact.
- G120V (p.Gly120Val), NCI-TCGA Cosmic COSV5747, cosmic curated COSV57471, Variant assessed as somatic; moderate impact.
- E122K (p.Glu122Lys), NCI-TCGA Cosmic COSV5747, cosmic curated COSV57470, Ensembl rs2121158233, Variant assessed as somatic; moderate impact.
- M123V (p.Met123Val), cosmic curated COSV10456, NCI-TCGA Cosmic COSV5746, NCI-TCGA Cosmic COSV9905, Variant assessed as somatic; moderate impact.
- R131* (p.Arg131Ter), NCI-TCGA Cosmic COSV5747, cosmic curated COSV57476, Variant assessed as somatic; high impact.
- R131Q (p.Arg131Gln), NCI-TCGA Cosmic COSV5747, cosmic curated COSV57476, REVEL 0.87, CADD 29.20, Variant assessed as somatic; moderate impact.
- P134A (p.Pro134Ala), rs2121153865, ClinGen CA386872024, ClinVar RCV003984944, AlphaMissense 1.00, MetaLR 0.97, Likely pathogenic, Ulnar-mammary syndrome
- P134S (p.Pro134Ser), NCI-TCGA Cosmic COSV5747, cosmic curated COSV57470, Ensembl rs2121153865, Variant assessed as somatic; moderate impact.
- K137* (p.Lys137Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- V138M (p.Val138Met), rs2499797131, ClinGen CA386871982, ClinVar RCV003991171, REVEL 0.90, CADD 27.60, Uncertain significance, Ulnar-mammary syndrome
- C140W (p.Cys140Trp), NCI-TCGA Cosmic COSV5747, Variant assessed as somatic; moderate impact.
- C140Y (p.Cys140Tyr), rs2499797118, ClinGen CA386871958, ClinVar RCV002833002, Uncertain significance, Ulnar-mammary syndrome
- L143P (p.Leu143Pro), UniProt VAR 009601, Pathogenic, in UMS
- A147P (p.Ala147Pro), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- K148N (p.Lys148Asn), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- Y149* (p.Tyr149Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact., in UMS
- Y149S (p.Tyr149Ser), UniProt VAR 009602, Pathogenic, in UMS
- I150S (p.Ile150Ser), NCI-TCGA Cosmic COSV9998, cosmic curated COSV99984, Variant assessed as somatic; moderate impact.
- L151Y (p.Leu151Tyr), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- D154G (p.Asp154Gly), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- D154Y (p.Asp154Tyr), NCI-TCGA Cosmic COSV5747, cosmic curated COSV57471, Variant assessed as somatic; moderate impact.
- D159H (p.Asp159His), NCI-TCGA Cosmic COSV5747, cosmic curated COSV57471, Variant assessed as somatic; moderate impact.
- D160G (p.Asp160Gly), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- D160R (p.Asp160Arg), NCI-TCGA Cosmic COSV9998, Variant assessed as somatic; high impact.
- R162L (p.Arg162Leu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- R162S (p.Arg162Ser), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- K164S (p.Lys164Ser), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- F165I (p.Phe165Ile), NCI-TCGA Cosmic COSV9998, cosmic curated COSV99983, Variant assessed as somatic; moderate impact.
- F165L (p.Phe165Leu), NCI-TCGA Cosmic COSV9998, Variant assessed as somatic; moderate impact.
- R169L (p.Arg169Leu), rs772182165, NCI-TCGA Cosmic COSV5746, cosmic curated COSV57469, NCI-TCGA Cosmic COSV5747, REVEL 0.84, CADD 29.60, Variant assessed as somatic; moderate impact.
- R169W (p.Arg169Trp), rs1430142395, NCI-TCGA Cosmic COSV5747, cosmic curated COSV57473, REVEL 0.73, CADD 33.00, Uncertain significance, Ulnar-mammary syndrome
- M171L (p.Met171Leu), rs905399897, ClinGen CA244153171, NCI-TCGA Cosmic COSV5746, cosmic curated COSV57469, REVEL 0.56, CADD 27.70, Uncertain significance, Inborn genetic diseases
- V172L (p.Val172Leu), NCI-TCGA Cosmic COSV9998, cosmic curated COSV99983, Variant assessed as somatic; moderate impact.
- K175T (p.Lys175Thr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A176S (p.Ala176Ser), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- E179K (p.Glu179Lys), rs754023417, NCI-TCGA Cosmic COSV9905, cosmic curated COSV99050, ExAC rs754023417, REVEL 0.82, CADD 28.50, Variant assessed as somatic; moderate impact.
- M180I (p.Met180Ile), NCI-TCGA TCGA novel, Ensembl rs2121153397, Variant assessed as somatic; moderate impact.
- P181S (p.Pro181Ser), NCI-TCGA Cosmic COSV5746, cosmic curated COSV57469, Ensembl rs2121153386, Variant assessed as somatic; moderate impact.
- M184G (p.Met184Gly), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- Y185C (p.Tyr185Cys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- Y185F (p.Tyr185Phe), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- H187D (p.His187Asp), rs767991404, ClinGen CA386871356, ClinVar RCV003620275, ClinVar RCV005235730, AlphaMissense 1.00, MetaLR 0.94, Uncertain significance, Ulnar-mammary syndrome; not provided
- H187Y (p.His187Tyr), NCI-TCGA Cosmic COSV5746, cosmic curated COSV57468, REVEL 0.95, CADD 29.20, Variant assessed as somatic; moderate impact.
- D189V (p.Asp189Val), NCI-TCGA Cosmic COSV9998, cosmic curated COSV99983, Variant assessed as somatic; moderate impact.
- A192S (p.Ala192Ser), NCI-TCGA Cosmic COSV5747, cosmic curated COSV57471, NCI-TCGA Cosmic COSV9998, Variant assessed as somatic; moderate impact.
- A192T (p.Ala192Thr), rs768160499, ClinGen CA6810172, NCI-TCGA Cosmic COSV5747, NCI-TCGA Cosmic COSV9998, REVEL 0.64, CADD 27.80, Uncertain significance, TBX3-related disorder
- W197* (p.Trp197Ter), NCI-TCGA Cosmic COSV5747, cosmic curated COSV57473, Variant assessed as somatic; high impact.
- S199Y (p.Ser199Tyr), NCI-TCGA Cosmic COSV5747, cosmic curated COSV57471, Variant assessed as somatic; moderate impact.
- F204S (p.Phe204Ser), NCI-TCGA Cosmic COSV9998, cosmic curated COSV99983, Variant assessed as somatic; moderate impact.
- H205N (p.His205Asn), NCI-TCGA Cosmic COSV5747, cosmic curated COSV57471, Variant assessed as somatic; moderate impact.
- T210H (p.Thr210His), NCI-TCGA Cosmic COSV5747, Variant assessed as somatic; high impact.
- N211T (p.Asn211Thr), rs756408358, NCI-TCGA Cosmic COSV5747, cosmic curated COSV57472, ExAC rs756408358, AlphaMissense 1.00, MetaLR 0.91, Variant assessed as somatic; moderate impact.
- G218* (p.Gly218Ter), NCI-TCGA Cosmic COSV5746, NCI-TCGA Cosmic COSV5747, Variant assessed as somatic; high impact.
- G218E (p.Gly218Glu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- F219I (p.Phe219Ile), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- T220=, NCI-TCGA TCGA novel, Variant assessed as somatic; low impact.
- A222T (p.Ala222Thr), NCI-TCGA TCGA novel, CADD 22.40, Variant assessed as somatic; moderate impact.
- F223S (p.Phe223Ser), NCI-TCGA Cosmic COSV9998, Variant assessed as somatic; moderate impact.
- P224Q (p.Pro224Gln), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- S225N (p.Ser225Asn), rs780398425, ClinGen CA6810137, ClinVar RCV003420853, CADD 23.10, Uncertain significance, TBX3-related disorder
- H227Q (p.His227Gln), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A228T (p.Ala228Thr), rs765693432, ClinGen CA6810135, NCI-TCGA Cosmic COSV5746, ClinVar RCV003410399, CADD 22.10, Uncertain significance, TBX3-related disorder
- T229M (p.Thr229Met), rs554364556, NCI-TCGA Cosmic COSV5747, CADD 25.10, Variant assessed as somatic; moderate impact.
- G232R (p.Gly232Arg), NCI-TCGA Cosmic COSV5746, Variant assessed as somatic; moderate impact.
- N243S (p.Asn243Ser), NCI-TCGA Cosmic COSV5747, Variant assessed as somatic; moderate impact.
- S244C (p.Ser244Cys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- Y248* (p.Tyr248Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- Y248N (p.Tyr248Asn), NCI-TCGA Cosmic COSV9998, cosmic curated COSV99983, Variant assessed as somatic; moderate impact.
- R251L (p.Arg251Leu), NCI-TCGA Cosmic COSV5747, NCI-TCGA Cosmic COSV9998, cosmic curated COSV99983, Variant assessed as somatic; moderate impact.
- H253Y (p.His253Tyr), NCI-TCGA Cosmic COSV5747, cosmic curated COSV57476, Variant assessed as somatic; moderate impact.
- R256K (p.Arg256Lys), rs1372907987, NCI-TCGA Cosmic COSV5747, cosmic curated COSV57474, gnomAD rs1372907987, AlphaMissense 0.89, MetaLR 0.70, Uncertain significance, Inborn genetic diseases
- N258S (p.Asn258Ser), rs375420460, ClinGen CA6810106, cosmic curated COSV99983, ClinVar RCV002751472, AlphaMissense 0.25, MetaLR 0.68, Uncertain significance, Ulnar-mammary syndrome
- L261F (p.Leu261Phe), NCI-TCGA Cosmic COSV9998, cosmic curated COSV99984, Variant assessed as somatic; moderate impact.
- Y265C (p.Tyr265Cys), NCI-TCGA Cosmic COSV9998, cosmic curated COSV99983, Variant assessed as somatic; moderate impact.
- Y265L (p.Tyr265Leu), NCI-TCGA Cosmic COSV9998, Variant assessed as somatic; high impact.
- S266C (p.Ser266Cys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- R269Q (p.Arg269Gln), rs775378442, ClinGen CA6810102, NCI-TCGA Cosmic COSV5746, cosmic curated COSV57469, AlphaMissense 0.81, MetaLR 0.75, Uncertain significance, Ulnar-mammary syndrome
- R269W (p.Arg269Trp), rs1198837775, NCI-TCGA Cosmic COSV5747, cosmic curated COSV57472, gnomAD rs1198837775, AlphaMissense 0.99, MetaLR 0.85, Uncertain significance, Inborn genetic diseases
- T270H (p.Thr270His), NCI-TCGA Cosmic COSV5747, Variant assessed as somatic; high impact.
- Y271* (p.Tyr271Ter), NCI-TCGA Cosmic COSV9998, cosmic curated COSV99983, Variant assessed as somatic; high impact.
- P274R (p.Pro274Arg), NCI-TCGA Cosmic COSV5747, cosmic curated COSV57474, Variant assessed as somatic; moderate impact.
- E275G (p.Glu275Gly), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- E275K (p.Glu275Lys), rs1234535767, NCI-TCGA Cosmic COSV5747, cosmic curated COSV57471, TOPMed rs1234535767, AlphaMissense 1.00, MetaLR 0.88, Variant assessed as somatic; moderate impact.
- T276P (p.Thr276Pro), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A280S (p.Ala280Ser), NCI-TCGA Cosmic COSV5746, cosmic curated COSV57469, NCI-TCGA Cosmic COSV5747, Variant assessed as somatic; moderate impact.
- A280T (p.Ala280Thr), NCI-TCGA Cosmic COSV5746, NCI-TCGA Cosmic COSV5747, cosmic curated COSV57474, TOPMed rs1868840212, Variant assessed as somatic; moderate impact.
- T282P (p.Thr282Pro), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- D287G (p.Asp287Gly), NCI-TCGA Cosmic COSV9905, cosmic curated COSV99050, Variant assessed as somatic; moderate impact.
- T290A (p.Thr290Ala), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- T290N (p.Thr290Asn), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- D295H (p.Asp295His), NCI-TCGA Cosmic COSV5747, cosmic curated COSV57473, Ensembl rs2121392048, Variant assessed as somatic; moderate impact.
- N296D (p.Asn296Asp), NCI-TCGA Cosmic COSV5746, cosmic curated COSV57469, NCI-TCGA Cosmic COSV5747, Variant assessed as somatic; moderate impact.
- N297T (p.Asn297Thr), rs2499791791, ClinGen CA386870233, ClinVar RCV003454376, ClinVar RCV004775403, Uncertain significance, not provided; Ulnar-mammary syndrome
- R304L (p.Arg304Leu), NCI-TCGA Cosmic COSV5746, Variant assessed as somatic; moderate impact.
- R304P (p.Arg304Pro), NCI-TCGA Cosmic COSV5746, Variant assessed as somatic; moderate impact.
- R304Q (p.Arg304Gln), NCI-TCGA Cosmic COSV5746, cosmic curated COSV57469, Ensembl rs2121391956, Variant assessed as somatic; moderate impact.
- R311K (p.Arg311Lys), NCI-TCGA Cosmic COSV5747, cosmic curated COSV57475, Variant assessed as somatic; moderate impact.
- E312* (p.Glu312Ter), NCI-TCGA Cosmic COSV5747, cosmic curated COSV57476, Variant assessed as somatic; high impact.
- Q316E (p.Gln316Glu), NCI-TCGA Cosmic COSV5746, cosmic curated COSV57469, Variant assessed as somatic; moderate impact.
- Q320* (p.Gln320Ter), NCI-TCGA TCGA novel, Ensembl rs2121389189, Variant assessed as somatic; high impact.
- Q320H (p.Gln320His), NCI-TCGA Cosmic COSV5747, cosmic curated COSV57476, Variant assessed as somatic; moderate impact.
- S321F (p.Ser321Phe), NCI-TCGA Cosmic COSV5747, cosmic curated COSV57476, Variant assessed as somatic; moderate impact.
- M322I (p.Met322Ile), NCI-TCGA Cosmic COSV5747, cosmic curated COSV57472, Variant assessed as somatic; moderate impact.
- F325V (p.Phe325Val), NCI-TCGA Cosmic COSV9998, Variant assessed as somatic; high impact.
- D326* (p.Asp326Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- N333K (p.Asn333Lys), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- S336Y (p.Ser336Tyr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- D337G (p.Asp337Gly), NCI-TCGA Cosmic COSV5746, cosmic curated COSV57469, Ensembl rs2121389085, Variant assessed as somatic; moderate impact.
- A345D (p.Ala345Asp), NCI-TCGA Cosmic COSV9998, cosmic curated COSV99983, Variant assessed as somatic; moderate impact.
- A345T (p.Ala345Thr), rs2499790211, ClinGen CA386869896, ClinVar RCV003621068, Uncertain significance, Ulnar-mammary syndrome
- F346L (p.Phe346Leu), NCI-TCGA Cosmic COSV5746, cosmic curated COSV57469, Variant assessed as somatic; moderate impact.
- A350T (p.Ala350Thr), rs773465537, ClinGen CA6810040, NCI-TCGA Cosmic COSV5747, cosmic curated COSV57471, AlphaMissense 0.08, MetaLR 0.65, Uncertain significance, Ulnar-mammary syndrome
- S354F (p.Ser354Phe), NCI-TCGA Cosmic COSV5747, cosmic curated COSV57471, Ensembl rs2121388953, Variant assessed as somatic; moderate impact.
- A357S (p.Ala357Ser), NCI-TCGA Cosmic COSV5746, cosmic curated COSV57469, ESP rs140580685, ExAC rs140580685, REVEL 0.16, AlphaMissense 0.13, Uncertain significance
- S363W (p.Ser363Trp), NCI-TCGA Cosmic COSV5747, cosmic curated COSV57474, Variant assessed as somatic; moderate impact.
- G373S (p.Gly373Ser), NCI-TCGA Cosmic COSV5746, cosmic curated COSV57469, Variant assessed as somatic; moderate impact.
- S375N (p.Ser375Asn), NCI-TCGA Cosmic COSV9998, cosmic curated COSV99983, Ensembl rs2121385745, Variant assessed as somatic; moderate impact.
- A377T (p.Ala377Thr), rs780968472, NCI-TCGA Cosmic COSV9998, cosmic curated COSV99983, ExAC rs780968472, AlphaMissense 0.13, MetaLR 0.60, Uncertain significance
- E380K (p.Glu380Lys), rs865915137, NCI-TCGA Cosmic COSV5747, cosmic curated COSV57470, TOPMed rs865915137, AlphaMissense 0.22, MetaLR 0.23, Uncertain significance
- E383K (p.Glu383Lys), rs2499788177, ClinGen CA386869645, ClinVar RCV002856132, Uncertain significance, Ulnar-mammary syndrome
- G386A (p.Gly386Ala), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- G386V (p.Gly386Val), rs2121385552, ClinGen CA386869619, ClinVar RCV002921611, AlphaMissense 0.07, MetaLR 0.42, Uncertain significance, Ulnar-mammary syndrome
- A389G (p.Ala389Gly), NCI-TCGA TCGA novel, Ensembl rs2121385489, Variant assessed as somatic; moderate impact.
- C390F (p.Cys390Phe), NCI-TCGA Cosmic COSV5747, Ensembl rs1868631530, Variant assessed as somatic; moderate impact.
- C390R (p.Cys390Arg), rs767883253, ExAC rs767883253, gnomAD rs767883253, AlphaMissense 0.13, MetaLR 0.36, Variant assessed as somatic; moderate impact.
- D391N (p.Asp391Asn), rs1180836314, NCI-TCGA Cosmic COSV5747, cosmic curated COSV57475, TOPMed rs1180836314, AlphaMissense 0.13, MetaLR 0.60, Variant assessed as somatic; moderate impact.
- A392T (p.Ala392Thr), NCI-TCGA Cosmic COSV9998, cosmic curated COSV99984, gnomAD rs1258048861, Variant assessed as somatic; moderate impact.
- A392V (p.Ala392Val), rs1214834962, NCI-TCGA Cosmic COSV5747, cosmic curated COSV57470, gnomAD rs1214834962, AlphaMissense 0.09, MetaLR 0.45, Variant assessed as somatic; moderate impact.
- T398A (p.Thr398Ala), NCI-TCGA Cosmic COSV9998, cosmic curated COSV99983, Variant assessed as somatic; moderate impact.
- T399M (p.Thr399Met), rs746953122, ClinGen CA6809987, ClinVar RCV003619880, ExAC rs746953122, AlphaMissense 0.29, MetaLR 0.80, Uncertain significance, Ulnar-mammary syndrome
- E401* (p.Glu401Ter), rs1457604010, ClinGen CA386869529, ClinVar RCV003392985, NCI-TCGA TCGA novel, AlphaMissense 0.15, MetaLR 0.60, Pathogenic
- E402* (p.Glu402Ter), NCI-TCGA Cosmic COSV5747, Variant assessed as somatic; high impact.
- P403A (p.Pro403Ala), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- P403L (p.Pro403Leu), rs746036481, ClinGen CA386869512, ClinVar RCV002796517, NCI-TCGA TCGA novel, AlphaMissense 0.12, MetaLR 0.55, Uncertain significance, Ulnar-mammary syndrome
Public TBX3 analysis runs
- TBX3 analysis run — TBX3 (697 variants) — completed 2026-08-22